本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mineralys Therapeutics, Inc.

26.34
+1.074.23%
盤後26.350.0100+0.04%19:46 EDT
成交量:86.40萬
成交額:2,267.39萬
市值:23.22億
市盈率:-6.02
高:26.67
開:25.47
低:25.38
收:25.27
52周最高:47.65
52周最低:14.53
股本:8,815.85萬
流通股本:6,602.58萬
量比:0.98
換手率:1.31%
股息:- -
股息率:- -
每股收益(TTM):-4.3763
每股收益(LYR):-2.2900
淨資產收益率:-80.88%
總資產收益率:-46.18%
市淨率:4.21
市盈率(LYR):-11.50

資料載入中...

2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]